Skip to main content
PMC home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1984 Jan;346:273–285. doi: 10.1113/jphysiol.1984.sp015021

Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat.

R Couture, A C Cuello
PMCID: PMC1199498  PMID: 6199494

Abstract

Antidromic stimulation of sensory peripheral branches of the trigeminal system (mental nerve) led to cutaneous vasodilatation and increased vascular permeability in rats anaesthetized with urethane. The antidromic vasodilatation observed in intact animals was not altered by decentralization or sympathectomy. Both antidromic vasodilatation and neurogenic plasma extravasation remained unaffected by pre-treatment with cimetidine, indomethacin, baclofen, guanethidine plus phentolamine and propranolol, but were significantly reduced by cimetidine plus mepyramine and atropine, suggesting that cholinergic and histaminergic components might be involved in the sensory neurogenic responses. Methysergide reduced only the extravasation, suggesting that probably serotonin liberated by mast cells upon sensory stimulation can contribute to the neurogenic responses. In tests using substance P (SP) antagonists (D-pro4, D- trp 7, 9, 10)-SP (4-11) and (D-pro2, D-trp 7, 9)-SP it was found that they are more active in reducing the neurogenic extravasation than the vasodilatation. In addition it was observed that (D-pro 4, D-trp 7, 9, 10)-SP (4-11) was the most potent substance P antagonist in reducing the plasma extravasation and antidromic vasodilatation resulting from sensory stimulation.

Full text

PDF
273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvier P. T., Chahl L. A., Ladd R. J. Modification by capsaicin and compound 48/80 of dye leakage induced by irritants in the rat. Br J Pharmacol. 1977 Jan;59(1):61–68. doi: 10.1111/j.1476-5381.1977.tb06977.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ballard D. R., Abboud F. M., Mayer H. E. Release of a humoral vasodilator substance during neurogenic vasodilatation. Am J Physiol. 1970 Nov;219(5):1451–1457. doi: 10.1152/ajplegacy.1970.219.5.1451. [DOI] [PubMed] [Google Scholar]
  3. Barthó L., Szolcsányi J. Opiate agonists inhibit neurogenic plasma extravasation in the rat. Eur J Pharmacol. 1981 Jul 17;73(1):101–104. doi: 10.1016/0014-2999(81)90152-7. [DOI] [PubMed] [Google Scholar]
  4. Bayliss W. M. On the origin from the spinal cord of the vaso-dilator fibres of the hind-limb, and on the nature of these fibres. J Physiol. 1901 Feb 28;26(3-4):173–209. doi: 10.1113/jphysiol.1901.sp000831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bell P. M., Stein R. B. A digital stimulator built on modular principles using integrated circuits. J Physiol. 1971 Oct;218 (Suppl):5P–5P. [PubMed] [Google Scholar]
  6. Bill A., Stjernschantz J., Mandahl A., Brodin E., Nilsson G. Substance P: release on trigeminal nerve stimulation, effects in the eye. Acta Physiol Scand. 1979 Jul;106(3):371–373. doi: 10.1111/j.1748-1716.1979.tb06412.x. [DOI] [PubMed] [Google Scholar]
  7. Blandina P., Fantozzi R., Mannaioni P. F., Masini E. Characteristics of histamine release evoked by acetylcholine in isolated rat mast cells. J Physiol. 1980 Apr;301:281–293. doi: 10.1113/jphysiol.1980.sp013205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Butler J. M., Hammond B. R. The effects of sensory denervation on the responses of the rabbit eye to prostaglandin E1, bradykinin and substance P. Br J Pharmacol. 1980 Jul;69(3):495–502. doi: 10.1111/j.1476-5381.1980.tb07040.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Couture R., Gaudreau P., St-Pierre S., Regoli D. The dog common carotid artery: a sensitive bioassay for studying vasodilator effects of substance P and of kinins. Can J Physiol Pharmacol. 1980 Oct;58(10):1234–1244. doi: 10.1139/y80-187. [DOI] [PubMed] [Google Scholar]
  10. Couture R., Regoli D. Mini review: smooth muscle pharmacology of substance P. Pharmacology. 1982;24(1):1–25. doi: 10.1159/000137572. [DOI] [PubMed] [Google Scholar]
  11. Cuello A. C., Del Fiacco M., Paxinos G. The central and peripheral ends of the substance P-containing sensory neurones in the rat trigeminal system. Brain Res. 1978 Sep 8;152(3):499–500. doi: 10.1016/0006-8993(78)91105-8. [DOI] [PubMed] [Google Scholar]
  12. Cutz E., Chan W., Track N. S., Goth A., Said S. I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature. 1978 Oct 19;275(5681):661–662. doi: 10.1038/275661a0. [DOI] [PubMed] [Google Scholar]
  13. Erjavec F., Lembeck F., Florjanc-Irman T., Skofitsch G., Donnerer J., Saria A., Holzer P. Release of histamine by substance P. Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):67–70. doi: 10.1007/BF00506259. [DOI] [PubMed] [Google Scholar]
  14. Fewtrell C. M., Foreman J. C., Jordan C. C., Oehme P., Renner H., Stewart J. M. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol. 1982 Sep;330:393–411. doi: 10.1113/jphysiol.1982.sp014347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Folkers K., Hörig J., Rosell S., Björkroth U. Chemical design of antagonists of substance P. Acta Physiol Scand. 1981 Apr;111(4):505–506. doi: 10.1111/j.1748-1716.1981.tb06771.x. [DOI] [PubMed] [Google Scholar]
  16. Foreman J. C., Jordan C. C., Piotrowski W. Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br J Pharmacol. 1982 Nov;77(3):531–539. doi: 10.1111/j.1476-5381.1982.tb09328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gamse R., Holzer P., Lembeck F. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol. 1980 Feb;68(2):207–213. doi: 10.1111/j.1476-5381.1980.tb10409.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Garcia Leme J., Hamamura L. Formation of a factor increasing vascular permeability during electrical stimulation of the saphenous nerve in rats. Br J Pharmacol. 1974 Jul;51(3):383–389. doi: 10.1111/j.1476-5381.1974.tb10673.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gazelius B., Olgart L. Vasodilatation in the dental pulp produced by electrical stimulation of the inferior alveolar nerve in the cat. Acta Physiol Scand. 1980 Feb;108(2):181–186. doi: 10.1111/j.1748-1716.1980.tb06516.x. [DOI] [PubMed] [Google Scholar]
  20. HOLTON F. A., HOLTON P. The capillary dilator substances in dry powders of spinal roots; a possible role of adenosine triphosphate in chemical transmission from nerve endings. J Physiol. 1954 Oct 28;126(1):124–140. doi: 10.1113/jphysiol.1954.sp005198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. HOLTON P., PERRY W. L. M. On the transmitter responsible for antidromic vasodilatation in the rabbit's ear. J Physiol. 1951 Jun;114(1-2):240–251. doi: 10.1113/jphysiol.1951.sp004615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hawcock A. B., Hayes A. G., Tyers M. B. Agonist effects of [D-Pro2,D-Phe7,D-Trp9]substance P--evidence for different receptors. Eur J Pharmacol. 1982 May 7;80(1):135–138. doi: 10.1016/0014-2999(82)90189-3. [DOI] [PubMed] [Google Scholar]
  23. Hedqvist P., von Euler U. S. Influence of substance P on the response of guinea pig ileum to transmural nerve stimulation. Acta Physiol Scand. 1975 Nov;95(3):341–343. doi: 10.1111/j.1748-1716.1975.tb10058.x. [DOI] [PubMed] [Google Scholar]
  24. Jancsó N., Jancsó-Gábor A., Szolcsányi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother. 1967 Sep;31(1):138–151. doi: 10.1111/j.1476-5381.1967.tb01984.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Johnson A. R., Erdös E. G. Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med. 1973 Apr;142(4):1252–1256. doi: 10.3181/00379727-142-37219. [DOI] [PubMed] [Google Scholar]
  26. Kiernan J. A. A pharmacological and histological investigation of the involvement of mast cells in cutaneous axon reflex vasodilatation. Q J Exp Physiol Cogn Med Sci. 1975 Apr;60(2):123–130. doi: 10.1113/expphysiol.1975.sp002298. [DOI] [PubMed] [Google Scholar]
  27. Kitada C., Ashida Y., Maki Y., Fujino M., Hirai Y., Yasuhara T., Nakajima T., Takeyama M., Koyama K., Yajima H. Synthesis of granuliberin-R and various fragment peptides and their histamine-releasing activities. Chem Pharm Bull (Tokyo) 1980 Mar;28(3):887–892. doi: 10.1248/cpb.28.887. [DOI] [PubMed] [Google Scholar]
  28. LEMBECK F. Zur Frage der zentralen Ubertragung afferenter Impulse. III. Das Vorkommen und die Bedeutung der Substanz P in den dorsalen Wurzeln des Rückenmarks. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;219(3):197–213. [PubMed] [Google Scholar]
  29. Langley J. N. Antidromic action: Part I. J Physiol. 1923 Aug 16;57(6):428–446. doi: 10.1113/jphysiol.1923.sp002081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Leander S., Håkanson R., Rosell S., Folkers K., Sundler F., Tornqvist K. A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature. 1981 Dec 3;294(5840):467–469. doi: 10.1038/294467a0. [DOI] [PubMed] [Google Scholar]
  31. Lembeck F., Donnerer J., Barthó L. Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide. Eur J Pharmacol. 1982 Nov 19;85(2):171–176. doi: 10.1016/0014-2999(82)90462-9. [DOI] [PubMed] [Google Scholar]
  32. Lembeck F., Donnerer J. Postocclusive cutaneous vasodilatation mediated by substance P. Naunyn Schmiedebergs Arch Pharmacol. 1981 Apr;316(2):165–171. doi: 10.1007/BF00505312. [DOI] [PubMed] [Google Scholar]
  33. Lembeck F., Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):175–183. doi: 10.1007/BF00500282. [DOI] [PubMed] [Google Scholar]
  34. Lundblad L., Anggård A., Lundberg J. M. Vasodilation in the ct nasal mucosa induced by antidromic trigeminal nerve stimulation. Acta Physiol Scand. 1982 Aug;115(4):517–519. doi: 10.1111/j.1748-1716.1982.tb07115.x. [DOI] [PubMed] [Google Scholar]
  35. Maling H. M., Webster M. E., Williams M. A., Saul W., Anderson W., Jr Inflammation induced by histamine, serotonin, bradykinin and compound 48-80 in the rat: antagonists and mechanisms of action. J Pharmacol Exp Ther. 1974 Nov;191(2):300–310. [PubMed] [Google Scholar]
  36. Mizrahi J., Escher E., Caranikas S., D'orléans-Juste P., Regoli D. Substance P antagonists active in vitro and in vivo. Eur J Pharmacol. 1982 Aug 13;82(1-2):101–105. doi: 10.1016/0014-2999(82)90561-1. [DOI] [PubMed] [Google Scholar]
  37. O'Dorisio M. S., O'Dorisio T. M., Cataland S., Balcerzak S. P. Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. J Lab Clin Med. 1980 Oct;96(4):666–672. [PubMed] [Google Scholar]
  38. Olgart L., Gazelius B., Brodin E., Nilsson G. Release of substance P-like immunoreactivity from the dental pulp. Acta Physiol Scand. 1977 Dec;101(4):510–512. doi: 10.1111/j.1748-1716.1977.tb06040.x. [DOI] [PubMed] [Google Scholar]
  39. Polak J. M., Bloom S. R. The distribution and significance of the VIPergic system in man and other mammals. Endocrinol Jpn. 1980 Dec;27 (Suppl 1):11–21. doi: 10.1507/endocrj1954.27.supplement_11. [DOI] [PubMed] [Google Scholar]
  40. ROWLEY D. A., BENDITT E. P. 5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J Exp Med. 1956 Apr 1;103(4):399–412. doi: 10.1084/jem.103.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rosell S., Olgart L., Gazelius B., Panopoulos P., Folkers K., Hörig J. Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist. Acta Physiol Scand. 1981 Mar;111(3):381–382. doi: 10.1111/j.1748-1716.1981.tb06752.x. [DOI] [PubMed] [Google Scholar]
  42. Rotter A., Birdsall N. J., Field P. M., Raisman G. Muscarinic receptors in the central nervous system of the rat. II. Distribution of binding of [3H]propylbenzilylcholine mustard in the midbrain and hindbrain. Brain Res. 1979;180(2):167–183. doi: 10.1016/0165-0173(79)90003-1. [DOI] [PubMed] [Google Scholar]
  43. Sandberg B. E., Iversen L. L. Substance P. J Med Chem. 1982 Sep;25(9):1009–1015. doi: 10.1021/jm00351a001. [DOI] [PubMed] [Google Scholar]
  44. Sawynok J. Theophylline-induced potentiation of the antinociceptive action of baclofen. Br J Pharmacol. 1983 Feb;78(2):353–357. doi: 10.1111/j.1476-5381.1983.tb09400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. V Euler U. S., Gaddum J. H. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931 Jun 6;72(1):74–87. doi: 10.1113/jphysiol.1931.sp002763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  47. Wamsley J. K., Zarbin M. A., Kuhar M. J. Muscarinic cholinergic receptors flow in the sciatic nerve. Brain Res. 1981 Jul 27;217(1):155–161. doi: 10.1016/0006-8993(81)90193-1. [DOI] [PubMed] [Google Scholar]
  48. Williams T. J. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol. 1982 Nov;77(3):505–509. doi: 10.1111/j.1476-5381.1982.tb09324.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yau W. M., Youther M. L. Direct evidence for a release of acetylcholine from the myenteric plexus of guinea pig small intestine by substance P. Eur J Pharmacol. 1982 Jul 30;81(4):665–668. doi: 10.1016/0014-2999(82)90357-0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES